Just a moment, the page is loading...

Grants and Funding

At Immunocore, we want to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases, by pioneering and delivering transformative immunomodulating medicine.

We recognize that medical science evolves rapidly with new information becoming available constantly. As part of the healthcare system, we also understand the need to support healthcare professionals in their pursuit of research activities and the most current education to provide the best patient care possible. There is further need to support patients, caregivers and communities to ensure that they have the information and medicines or treatments to support healthy, quality, and productive lives.

As such, we are proud to have the opportunity to consider funding applications for:

Cutaneous Melanoma: Rational sequencing or combination strategies addressing mechanisms for overcoming resistance (primary and/or secondary)






Area of Interest Details
Tebentafusp
1 May 2025
13 June 2025
4 Aug 2025


MM-UK--2500001
Date of production: March 2025